Laboratory diagnosis of von Willebrand disease

Hamostaseologie

Volumn 30, Issue 4, 2010, Pages 203-206

  Patzke, Jürgen ^a   Schneppenheim, R ^b  

^a Siemens Healthcare Diagnostics Products GmbH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Von Willebrand disease; Von Willebrand factor

Indexed keywords

GLYCOPROTEIN IB ALPHA; POLYMER; RISTOCETIN;

ANTIBODY COMBINING SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC SCREENING; HUMAN; IMMUNOASSAY; LABORATORY TEST; REVIEW; SURVIVAL; VON WILLEBRAND DISEASE;

EID: 78650012411     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619057     Document Type: Review

References (29)

1. Nichols WL, Hultin MB, James AH et al. Von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia 2008; 14: 171-232.
2. Favaloro EJ. Laboratory identification of von Willebrand disease: Technical and scientific perspectives. Semin Thromb Hemost 2006; 32: 456-471. (Pubitemid 44157383)
3. Federici AB. Classification of inherited von Willebrand disease and implications in clinical practice. Thromb Res 2009; 124 (Suppl 1): S2-S6.
4. Domsch C, Calatzis A, Schramm W, Spannagl M. Parallel determination of ristocetin cofactor activity and von Willebrand factor antigen. 45. Jahrestagung der GTH, Düsseldorf 2001: Poster 37.
5. Strandberg K, Andersson K, Carlson M et al. Evaluation of an automated assay for rapid analysis of von Willebrand ristocetin cofactor activity. J Thromb Haemost 2003; 1 (Suppl 1): P1676.
6. Strandberg K, Lethagen S, Andersson K et al. Evaluation of a rapid automated assay for analysis of von Willebrand Ristocetin Cofactor Activity. Clin Appl Thromb Hemost 2006; 12: 61-67.
7. Tosetto A, Rodeghiero R, Castaman G et al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost 2007; 5: 715-721.
8. Favaloro EJ, Aboud M, Arthur C. Possibility of potential VWD misdiagnosis or misclassification using LIA technology and due to presence of rheumatoid factor. Am J Hematol 2001; 66: 53-56. (Pubitemid 32006324)
9. th International Congress of the World Federation of Hemophilia, Bangkok, Thailand, Oct 17-21, 2004.
10. Pinol M, Sales M, Costa M et al. Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease. Haematologica 2007; 92: 712-713. (Pubitemid 350144282)
11. De Vleeschauwer A, Devreese K. Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease. Blood Coagul Fibrinol 2006; 17: 353-358. (Pubitemid 43941577)
12. Salem RO, van Cott E. A new automated screening assay for the diagnosis of von Willebrand disease. Am J Clin Pathol 2007; 127: 730-735.
13. Budde U, Pieconka A, Will K, Schneppenheim R. Laboratory testing for von Willebrand disease: Contribution of multimer analysis to diagnosis and classification. Semin Thromb Hemost 2006; 32: 514-521. (Pubitemid 44157390)
14. Ott HW, Griesmacher A, Schnapka-Koepf M et al. Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detection. Am J Clin Pathol 2010; 133: 322-330.
15. Budde U, Schneppenheim R, Eikenboom J et al. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost 2008; 6: 762-771.
16. Vanhoorelbeke K, Cauwenberghs N, Vauterin S et al. A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor. Thromb Haemost. 2000; 83: 107-113.
17. Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G et al. A reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease. Semin Thromb Hemost 2002; 28: 161-166.
18. Federici AB, Canciani MT, Forza I et al. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels. Haematologica 2004; 89: 77-85. (Pubitemid 38165858)
19. Tous J, Barry RG, Arnout J et al. New automated chemiluminescent VWF:Ag and VWF:RCo assays: preliminary analytical and clinical performance. J Thromb Haemost 2009; 7 (Suppl 2): PP-TH-625.
20. Pinol M, Sanchez T, Sales M et al. New automated ristocetin cofactor activity assay to distinguish type 1 and type 2 von Willebrand disease (VWD). J Thromb Haemost 2009; 7 (Suppl 2): PP-TH-635.
21. Flood VH, Friedman KD, Gill JC et al. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function. J Thromb Haemost 2009; 7: 1832-1839.
22. Schneppenheim R, Obser T, Budde U, Patzke J. Development of a new functional assay for von Willebrand factor binding to platelet GpIba that does not require Ristocetin. Hämostaseologie 2010; 30: A28, FC4-05.
23. Patzke J, Althaus H, Schneppenheim R. Development of a new particle enhanced agglutination VWF activity assay with no need of ristocetin. Hämostaseologie 2010; 30: P07-02.
24. Patzke J, Althaus H, Budde U et al. Evaluation of a new VWF activity assay based on GPIbα binding in the absence of ristocetin. Hämostaseologie 2010; 30: P07-03.
25. Haberichter SL, Balistreri M, Christopherson P et al. Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood 2006; 108: 3344-3351
26. Sztukowska M, Gallinaro L, Cattini MG et al. Von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. Br J Haematol 2008; 143: 107-114.
27. Favaloro EJ. Genetic testing of von Willebrand disease: the case against. J Thromb Haemost 2010; 8: 6-12.
28. Peake IR, Goodeve AC. Genetic testing of von Willebrand disease: the case for. J Thromb Haemost 2010; 8: 13-16.
29. Goodeve A, Eikenboom J, Castaman G et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-121.